142 related articles for article (PubMed ID: 22949185)
1. The role of active-site Phe87 in modulating the organic co-solvent tolerance of cytochrome P450 BM3 monooxygenase.
Kuper J; Tee KL; Wilmanns M; Roccatano D; Schwaneberg U; Wong TS
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Sep; 68(Pt 9):1013-7. PubMed ID: 22949185
[TBL] [Abstract][Full Text] [Related]
2. Toward understanding the inactivation mechanism of monooxygenase P450 BM-3 by organic cosolvents: a molecular dynamics simulation study.
Roccatano D; Wong TS; Schwaneberg U; Zacharias M
Biopolymers; 2006 Dec; 83(5):467-76. PubMed ID: 16862534
[TBL] [Abstract][Full Text] [Related]
3. Novel haem co-ordination variants of flavocytochrome P450BM3.
Girvan HM; Toogood HS; Littleford RE; Seward HE; Smith WE; Ekanem IS; Leys D; Cheesman MR; Munro AW
Biochem J; 2009 Jan; 417(1):65-76. PubMed ID: 18721129
[TBL] [Abstract][Full Text] [Related]
4. Glutamate-haem ester bond formation is disfavoured in flavocytochrome P450 BM3: characterization of glutamate substitution mutants at the haem site of P450 BM3.
Girvan HM; Levy CW; Williams P; Fisher K; Cheesman MR; Rigby SE; Leys D; Munro AW
Biochem J; 2010 Apr; 427(3):455-66. PubMed ID: 20180779
[TBL] [Abstract][Full Text] [Related]
5. Structural and dynamic properties of cytochrome P450 BM-3 in pure water and in a dimethylsulfoxide/water mixture.
Roccatano D; Wong TS; Schwaneberg U; Zacharias M
Biopolymers; 2005 Aug; 78(5):259-67. PubMed ID: 15880388
[TBL] [Abstract][Full Text] [Related]
6. The role of cytochrome P450 BM3 phenylalanine-87 and threonine-268 in binding organic hydroperoxides.
Roberts AG; Katayama J; Kaspera R; Ledwitch KV; Le Trong I; Stenkamp RE; Thompson JA; Totah RA
Biochim Biophys Acta; 2016 Apr; 1860(4):669-77. PubMed ID: 26723172
[TBL] [Abstract][Full Text] [Related]
7. Structure, electronic properties and catalytic behaviour of an activity-enhancing CYP102A1 (P450(BM3)) variant.
Whitehouse CJ; Yang W; Yorke JA; Tufton HG; Ogilvie LC; Bell SG; Zhou W; Bartlam M; Rao Z; Wong LL
Dalton Trans; 2011 Oct; 40(40):10383-96. PubMed ID: 21603690
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the oxidation of short chain alkynes by flavocytochrome P450 BM3.
Waltham TN; Girvan HM; Butler CF; Rigby SR; Dunford AJ; Holt RA; Munro AW
Metallomics; 2011 Apr; 3(4):369-78. PubMed ID: 21431175
[TBL] [Abstract][Full Text] [Related]
9. Molecular Lego: design of molecular assemblies of P450 enzymes for nanobiotechnology.
Gilardi G; Meharenna YT; Tsotsou GE; Sadeghi SJ; Fairhead M; Giannini S
Biosens Bioelectron; 2002 Jan; 17(1-2):133-45. PubMed ID: 11742744
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the structure and interactions of P450 BM3 using hybrid mass spectrometry approaches.
Jeffreys LN; Pacholarz KJ; Johannissen LO; Girvan HM; Barran PE; Voice MW; Munro AW
J Biol Chem; 2020 May; 295(22):7595-7607. PubMed ID: 32303637
[TBL] [Abstract][Full Text] [Related]
11. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
12. Primary culture of rat hepatocytes in the presence of dimethyl sulphoxide. A system to investigate the regulation of cytochrome P450 IA.
Lindsay CK; Chenery RJ; Hawksworth GM
Biochem Pharmacol; 1991 Dec; 42 Suppl():S17-25. PubMed ID: 1768275
[TBL] [Abstract][Full Text] [Related]
13. Effect of Organic Solvents on the Structure and Activity of a Minimal Lipase.
Ingenbosch KN; Vieyto-Nuñez JC; Ruiz-Blanco YB; Mayer C; Hoffmann-Jacobsen K; Sanchez-Garcia E
J Org Chem; 2022 Feb; 87(3):1669-1678. PubMed ID: 34706196
[TBL] [Abstract][Full Text] [Related]
14. Laboratory evolution of cytochrome p450 BM-3 monooxygenase for organic cosolvents.
Wong TS; Arnold FH; Schwaneberg U
Biotechnol Bioeng; 2004 Feb; 85(3):351-8. PubMed ID: 14748091
[TBL] [Abstract][Full Text] [Related]
15. Crystallographic insights into a cobalt (III) sepulchrate based alternative cofactor system of P450 BM3 monooxygenase.
Panneerselvam S; Shehzad A; Mueller-Dieckmann J; Wilmanns M; Bocola M; Davari MD; Schwaneberg U
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):134-140. PubMed ID: 28739446
[TBL] [Abstract][Full Text] [Related]
16. Interaction of nitric oxide with cytochrome P450 BM3.
Quaroni LG; Seward HE; McLean KJ; Girvan HM; Ost TW; Noble MA; Kelly SM; Price NC; Cheesman MR; Smith WE; Munro AW
Biochemistry; 2004 Dec; 43(51):16416-31. PubMed ID: 15610036
[TBL] [Abstract][Full Text] [Related]
17. NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450 cam.
Modi S; Primrose WU; Boyle JM; Gibson CF; Lian LY; Roberts GC
Biochemistry; 1995 Jul; 34(28):8982-8. PubMed ID: 7619797
[TBL] [Abstract][Full Text] [Related]
18. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
19. First steps towards a Zn/Co(III)sep-driven P450 BM3 reactor.
Zhao L; Güven G; Li Y; Schwaneberg U
Appl Microbiol Biotechnol; 2011 Aug; 91(4):989-99. PubMed ID: 21562982
[TBL] [Abstract][Full Text] [Related]
20. Laboratory evolution of P450 BM3 for mediated electron transfer yielding an activity-improved and reductase-independent variant.
Nazor J; Dannenmann S; Adjei RO; Fordjour YB; Ghampson IT; Blanusa M; Roccatano D; Schwaneberg U
Protein Eng Des Sel; 2008 Jan; 21(1):29-35. PubMed ID: 18093991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
